ATI Pharmacology Exam

Correct Answer:

I will watch for increased breast tissue growth while taking this medication.

Explanation:

This is the correct answer. Spironolactone is a potassium-sparing diuretic and an aldosterone antagonist that is used to manage conditions such as heart failure, hypertension, and ascites. A known side effect of spironolactone is gynecomastia, which is the development of breast tissue in men, and in some cases, it can cause breast tenderness in women. This occurs because spironolactone has anti-androgenic properties, meaning it blocks the action of male hormones like testosterone and can sometimes increase the effects of estrogen. Monitoring for breast tissue growth or tenderness is a crucial part of patient education while taking spironolactone, and the client should report any changes. This shows an understanding of the medication's potential endocrine-related adverse effects.

Why Other Options Are Wrong:

I will increase my intake of citrus fruits, bananas, and potatoes.

This is incorrect because citrus fruits, bananas, and potatoes are all high in potassium. Spironolactone is a potassium-sparing diuretic, meaning it prevents the body from excreting potassium, which could lead to hyperkalemia (high potassium levels). Hyperkalemia can cause dangerous heart arrhythmias, and consuming more potassium-rich foods would exacerbate this risk. Therefore, the client should limit potassium intake or monitor it carefully, not increase it.

I will use salt substitutes on my food.

This is incorrect because many salt substitutes contain potassium chloride, which can further elevate potassium levels when taken with a potassium-sparing diuretic like spironolactone. Excessive potassium can cause hyperkalemia, which can lead to severe cardiac issues, including arrhythmias or cardiac arrest. Clients on spironolactone should avoid salt substitutes unless specifically directed by their healthcare provider.

I will drink as much water as I can while taking this medication.

This is incorrect because, while staying hydrated is important, excessive water intake can lead to dilutional hyponatremia (low sodium levels), which disrupts the electrolyte balance. For clients with heart failure or kidney conditions, too much fluid intake can lead to volume overload, causing symptoms like swelling, shortness of breath, and exacerbating heart failure. Fluid intake should be carefully monitored and regulated based on the client's specific medical needs and the provider's instructions.

Summary:

Spironolactone can cause hormonal side effects like gynecomastia, so it is crucial for the client to be aware of this potential change and report it. The other options promote behaviors that could increase potassium levels or fluid overload, both of which pose significant risks when taking spironolactone. The correct teaching focuses on the medication's known endocrine-related side effects.

Correct Answer D. Check the client's respirations every 2 hr.

Explanation of Correct Answer:

D. Check the client's respirations every 2 hr.

The most critical assessment for a client using a PCA (patient-controlled analgesia) pump is monitoring respiratory status. PCA pumps, especially those delivering opioids like morphine, can cause respiratory depression, which can be life-threatening. It is crucial to monitor the client's respirations frequently, particularly during the first 24 hours, when the effects of the medication are most prominent. Checking respirations every 2 hours helps ensure that the client does not experience hypoventilation or respiratory distress.

Why the Other Options Are Incorrect:

A. Check the client's pulse oximetry level every 6 hr.

This is incorrect because while pulse oximetry is important, monitoring it every 6 hours is not frequent enough in the first 24 hours after surgery, especially when opioids are being used. Respiratory depression can develop quickly, so more frequent checks (every 2 hours) are recommended.

B. Assess the client's apical heart rate every 8 hr.

This is incorrect because assessing the apical heart rate every 8 hours is not sufficient for a postoperative patient receiving PCA. Respiratory monitoring is more critical in this scenario due to the risk of respiratory depression from opioid medications.

C. Check the client's blood pressure every 4 hr.

This is incorrect because although blood pressure monitoring is important, it is not as critical as monitoring respirations in the first 24 hours after surgery when using a PCA pump. Respiratory depression is a more immediate concern that requires closer attention.

Correct Answer B. A young adult who has a febrile illness

Explanation of Correct Answer:

B. A young adult who has a febrile illness

The inactivated influenza vaccine should not be administered to individuals who are currently experiencing a febrile illness. A fever is an indication of an active infection or immune response, which may interfere with the body's ability to respond properly to the vaccine. Administering vaccines during an illness can also increase the risk of side effects. It is essential to delay immunization until the fever subsides and the person is in stable health.

Why the Other Options Are Incorrect:

A. A child who has a hypersensitivity to amoxicillin

This is incorrect because hypersensitivity to amoxicillin is not a contraindication for the inactivated influenza vaccine. Amoxicillin is an antibiotic used for bacterial infections, and it does not have any direct interaction with the components of the influenza vaccine. Vaccine contraindications are typically related to severe reactions to previous doses or to vaccine components such as egg proteins.

C. A young adult who is pregnant

This is incorrect because the inactivated influenza vaccine is safe for pregnant women. The vaccine does not contain live virus and can be administered safely during pregnancy to protect both the mother and the fetus from influenza-related complications.

D. A child who has cerebral palsy

This is incorrect because cerebral palsy is not a contraindication for receiving the inactivated influenza vaccine. Children with cerebral palsy, like others, are at increased risk for respiratory complications from influenza, and vaccination is recommended to reduce this risk.

Correct Answer B. Bone loss

Explanation of Correct Answer:

B. Bone loss

Prednisone is a glucocorticoid, and long-term use of glucocorticoids is known to increase the risk of bone loss (osteoporosis). Glucocorticoids can interfere with calcium absorption and bone formation, leading to bone thinning and fractures. Monitoring for bone loss is a critical aspect of care for patients on long-term prednisone therapy.

Why the Other Options Are Incorrect:

A. Liver toxicity

While certain medications can cause liver toxicity, prednisone does not commonly cause significant liver damage. The primary concerns with long-term corticosteroid use are related to bone health, immune suppression, and metabolic disturbances.

C. Hemolytic anemia

Hemolytic anemia is not a common adverse effect of prednisone. While prednisone can affect blood cells in some ways (e.g., by suppressing immune function), hemolytic anemia is not a typical concern.

D. Hypoglycemia

Prednisone generally raises blood sugar levels due to its effects on carbohydrate metabolism. It is more likely to cause hyperglycemia rather than hypoglycemia, especially in diabetic patients or those predisposed to blood sugar abnormalities.

Correct Answer:

Albuterol

Explanation:

Albuterol is a short-acting beta2-adrenergic agonist (SABA) that serves as the first-line rescue medication for acute asthma symptoms. It acts quickly by stimulating beta2 receptors in the bronchial smooth muscle, causing rapid bronchodilation and relief of bronchospasm. This leads to improved airflow and reduction in symptoms such as wheezing, coughing, and shortness of breath. Because of its fast onset—typically within minutes—albuterol is the medication of choice for treating acute asthma attacks in both pediatric and adult populations. It is essential in emergency asthma management and is often administered via metered-dose inhaler or nebulizer.

Why Other Options Are Wrong:

Salmeterol

This is incorrect because salmeterol is a long-acting beta2-adrenergic agonist (LABA), not intended for immediate symptom relief. It is used as part of long-term asthma control to prevent nighttime or exercise-induced symptoms. Due to its delayed onset of action, it is not effective in acute bronchospasm situations. Using salmeterol as a rescue medication would delay appropriate treatment and could worsen the patient’s condition during an asthma attack.

Cromolyn

This is not appropriate for acute asthma attacks because cromolyn is a mast cell stabilizer that works by preventing the release of inflammatory mediators. It is used prophylactically to reduce the frequency of asthma symptoms, particularly those triggered by allergens or exercise. However, it has no bronchodilating effect and does not reverse acute bronchospasm. Relying on cromolyn during an asthma attack would fail to provide the rapid relief needed in an emergency.

Fluticasone

This is incorrect because fluticasone is an inhaled corticosteroid used for long-term control and reduction of airway inflammation in asthma management. It does not have an immediate bronchodilating effect and therefore is ineffective in treating acute asthma symptoms. Fluticasone must be used regularly over time to be effective and should not replace a fast-acting rescue inhaler. Using it during an acute attack could lead to delays in appropriate treatment and respiratory deterioration.

Correct Answer:

Regular insulin

Explanation:

Regular insulin is the only insulin formulation approved for intravenous (IV) administration, making it the standard choice for managing diabetic ketoacidosis (DKA). DKA is a serious complication of diabetes characterized by hyperglycemia, ketosis, and metabolic acidosis. To address the acute effects of DKA, insulin is needed to rapidly reduce blood glucose levels and suppress ketone production. Regular insulin has a rapid onset of action, which makes it suitable for IV infusion to provide prompt correction of metabolic disturbances. Its safety profile for IV use is well-established, and it remains the recommended insulin for this purpose.

Why Other Options Are Wrong:

Insulin lispro

This is incorrect because insulin lispro is a rapid-acting insulin, but it is not approved for intravenous use in the treatment of DKA. While insulin lispro is effective for controlling blood glucose levels, especially after meals, its use is limited to subcutaneous administration. It does not have the appropriate pharmacokinetic properties for IV use in acute settings like DKA, where regular insulin is preferred for its predictable and rapid action.

Insulin aspart

This is incorrect because insulin aspart, like insulin lispro, is a rapid-acting insulin designed for subcutaneous injection around meal times. It is not recommended for intravenous administration in DKA. Although it works quickly to lower blood sugar when administered subcutaneously, it is not used intravenously due to the lack of established safety and efficacy for that route in DKA management.

Insulin glargine

This is incorrect because insulin glargine is a long-acting insulin that is designed for subcutaneous administration. It has a steady, prolonged release profile and is not intended for intravenous use. Administering insulin glargine intravenously would alter its pharmacodynamics, making it ineffective and potentially dangerous for managing the acute phases of DKA, where rapid control of blood glucose is critical.

Correct Answer C. Furosemide

Explanation of Correct Answer:

C. Furosemide

Furosemide is a loop diuretic that may interact with vancomycin, increasing the risk of nephrotoxicity and ototoxicity. Both vancomycin and furosemide can cause damage to the kidneys, and when used together, this risk is compounded. It is important to monitor kidney function closely when these two medications are administered concurrently to avoid potential harm.

Why the Other Options Are Incorrect:

A. Morphine

This is incorrect because morphine does not significantly interact with vancomycin. While both medications may be used together to manage pain and infection, there is no significant pharmacological interaction between the two.

B. Nitroglycerin

This is incorrect because nitroglycerin does not interact with vancomycin. Nitroglycerin is used to treat angina and does not have any known harmful interaction with vancomycin.

D. Calcium chloride

This is incorrect because calcium chloride does not directly interact with vancomycin. However, caution should be used when administering calcium products with other medications, especially in cases of rapid administration or electrolyte imbalances, but no significant interaction with vancomycin is typically seen.

Correct Answer:

I will need to depress the side arms to activate the pump

Explanation:

Calcitonin-salmon nasal spray is delivered via a metered-dose device that requires proper activation before the first use. The client must depress the side arms of the pump to prime the spray, ensuring that a full, consistent dose is delivered with each use. This priming process clears air from the device and allows the medication to be dispensed accurately. Proper technique is essential for effective therapy and medication safety, particularly for managing chronic conditions such as osteoporosis.

Why Other Options Are Wrong:

I will administer a spray into each nostril daily

This is incorrect because the recommended method is to spray into one nostril daily, alternating nostrils each day. Administering into both nostrils can increase the risk of nasal irritation, dryness, or crusting, which are potential side effects of this medication. Alternating nostrils helps minimize localized irritation and supports continued tolerability during long-term use. Incorrect usage could lead to discomfort or reduce adherence to therapy.

I should expect nasal bleeding for the first week

This statement is false. While mild nasal irritation or dryness may occur, nasal bleeding is not a normal or expected side effect and should be reported to a healthcare provider. Persistent or frequent bleeding could indicate mucosal damage or an adverse reaction that may warrant changing the route or discontinuing the medication. Dismissing bleeding as normal could delay important clinical interventions.

I should expect to take this medication for a short-term course of treatment

Incorrect. Calcitonin-salmon is typically used for long-term management of postmenopausal osteoporosis to prevent bone loss and reduce fracture risk. It is not a short-term therapy; consistent use over time is necessary to achieve therapeutic benefits. Misunderstanding the duration of treatment could lead to premature discontinuation and reduced effectiveness in managing the condition.

Correct Answer C. Dual-energy x-ray absorptiometry (Dexa scan)

Explanation of Correct Answer:

C. Dual-energy x-ray absorptiometry (Dexa scan)

The effectiveness of alendronate, a medication used to treat osteoporosis, is typically evaluated by monitoring changes in bone mineral density (BMD). The Dual-energy x-ray absorptiometry (Dexa scan) is the gold standard for assessing BMD and evaluating the progression or improvement of osteoporosis. The nurse should review the results of a recent Dexa scan to determine how well the treatment with alendronate is working.

Why the Other Options Are Incorrect:

A. Hemoglobin A1C (Hb A1C)

This is incorrect because the Hemoglobin A1C test is used to monitor long-term blood glucose control in patients with diabetes, not osteoporosis. It is not relevant for evaluating the effectiveness of alendronate.

B. Urine specific gravity

This is incorrect because urine specific gravity is a measure of urine concentration, typically used to assess kidney function or hydration status. It is not used to monitor bone density or the effectiveness of osteoporosis treatment.

D. Lumbar puncture

This is incorrect because a lumbar puncture is a procedure used to obtain cerebrospinal fluid for diagnosing conditions related to the central nervous system, such as infections or neurological disorders. It is not relevant to evaluating the effectiveness of alendronate in treating osteoporosis.